Do we need an irritable subtype of ADHD? Replication and extension of a promising temperament profile approach to ADHD subtyping.


Journal

Psychological assessment
ISSN: 1939-134X
Titre abrégé: Psychol Assess
Pays: United States
ID NLM: 8915253

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 26 10 2018
medline: 4 4 2019
entrez: 26 10 2018
Statut: ppublish

Résumé

Attention deficit hyperactivity disorder (ADHD) is emblematic of unresolved heterogeneity in psychiatric disorders-the variation in biological, clinical, and psychological correlates that impedes progress on etiology. One approach to this problem is to characterize subgroups using measures rooted in biological or psychological theory, consistent with the National Institute of Mental Health's research domain criteria initiative. Within ADHD, a promising application involves using emotion trait profiles that can address the role of irritability as a complicating feature for ADHD. Here, a new sample of 186 children with ADHD was evaluated using community detection analysis to determine if meaningful subprofiles existed and if they replicated those previously identified. The new sample and a prior sample were pooled for evaluation of (a) method dependence, (b) longitudinal assessment of the stability of classifications, and (c) clinical prediction 2 years later. Three temperament profiles were confirmed within the ADHD group: one with normative emotional functioning ("mild"), one with high surgency ("surgent"), and one with high negative affect ("irritable"). Profiles were similar across statistical clustering approaches. The irritable group had the highest external validity: It was moderately stable over time and it enhanced prospective prediction of clinical outcomes beyond standard baseline indicators. The irritable group was not reducible to ADHD + oppositional defiant disorder, ADHD + disruptive mood dysregulation disorder, or other patterns of comorbidity. Among the negative affect domains studied, trait proneness to anger uniquely contributed to clinical prediction. Results extend our understanding of chronic irritability in psychiatric disorders and provide prospects for a fresh approach to assessing ADHD heterogeneity focused on the distinction between ADHD with and without anger/irritability. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Identifiants

pubmed: 30359050
pii: 2018-53431-001
doi: 10.1037/pas0000664
pmc: PMC6345612
mid: NIHMS988984
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

236-247

Subventions

Organisme : NIMH NIH HHS
ID : R37 MH059105
Pays : United States
Organisme : NIMH NIH HHS
ID : R03 MH110812
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR000129
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR002371
Pays : United States
Organisme : National Institutes of Health; National Center for Advancing Translational Sciences
Organisme : NIMH NIH HHS
ID : K23 MH108656
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH115357
Pays : United States

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Am J Psychiatry. 2011 Feb;168(2):129-42
pubmed: 21123313
J Child Adolesc Psychopharmacol. 2006 Aug;16(4):456-66
pubmed: 16958570
J Child Psychol Psychiatry. 2006 Nov;47(11):1175-83
pubmed: 17076757
J Am Acad Child Adolesc Psychiatry. 1999 Jan;38(1):25-33
pubmed: 9893413
Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6769-74
pubmed: 22474392
J Child Psychol Psychiatry. 1999 Jul;40(5):791-9
pubmed: 10433412
Depress Anxiety. 2015 May;32(5):364-72
pubmed: 25504765
Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8577-82
pubmed: 16723398
J Am Acad Child Adolesc Psychiatry. 2015 Aug;54(8):626-34
pubmed: 26210331
Arch Gen Psychiatry. 2005 Aug;62(8):896-902
pubmed: 16061767
Psychol Sci Public Interest. 2017 Sep;18(2):72-145
pubmed: 29211974
J Am Acad Child Adolesc Psychiatry. 2016 Jul;55(7):556-70
pubmed: 27343883
Perspect Psychol Sci. 2012 Nov;7(6):528-30
pubmed: 26168108
Neuroimage. 2011 Jun 15;56(4):2068-79
pubmed: 21459148
Chaos. 2013 Mar;23(1):013142
pubmed: 23556979
J Affect Disord. 2017 Jul;216:109-116
pubmed: 27692699
Am J Psychiatry. 2009 Sep;166(9):1048-54
pubmed: 19570932
Am J Psychiatry. 2010 Jul;167(7):748-51
pubmed: 20595427
Perspect Psychol Sci. 2012 Nov;7(6):645-54
pubmed: 26168125
World Psychiatry. 2014 Feb;13(1):28-35
pubmed: 24497240
Eur Child Adolesc Psychiatry. 2011 Feb;20(2):61-6
pubmed: 21298306
J Clin Psychiatry. 2012 Oct;73(10):1342-50
pubmed: 23140653
J Child Psychol Psychiatry. 2004 Mar;45(3):589-98
pubmed: 15055377
Dev Psychopathol. 2000 Summer;12(3):427-41
pubmed: 11014746
Perspect Psychol Sci. 2012 Nov;7(6):537-42
pubmed: 26168110
J Am Acad Child Adolesc Psychiatry. 2008 Jan;47(1):76-85
pubmed: 18174828
Eur Child Adolesc Psychiatry. 2009 Nov;18(11):691-700
pubmed: 19462154
Pediatrics. 2011 Mar;127(3):462-70
pubmed: 21300675
Neurosci Biobehav Rev. 2006;30(4):511-25
pubmed: 16289282
JAMA Psychiatry. 2014 Sep;71(9):1015-24
pubmed: 25006969
Ann N Y Acad Sci. 2003 Dec;1008:201-18
pubmed: 14998886
J Child Psychol Psychiatry. 2006 Mar-Apr;47(3-4):395-422
pubmed: 16492265
J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1337-45
pubmed: 11699809
J Pers Disord. 2008 Aug;22(4):313-31
pubmed: 18684047
Psychiatry Res. 2009 Dec 30;170(2-3):192-8
pubmed: 19900717
Eur Child Adolesc Psychiatry. 2010 Mar;19(3):311-23
pubmed: 20213230
J Am Acad Child Adolesc Psychiatry. 2009 Apr;48(4):441-450
pubmed: 19318883
Am J Psychiatry. 2012 Jan;169(1):47-54
pubmed: 22193524
Am J Psychiatry. 2014 Mar;171(3):276-93
pubmed: 24480998

Auteurs

Sarah L Karalunas (SL)

Department of Psychiatry, Oregon Health & Science University.

Hanna C Gustafsson (HC)

Department of Psychiatry, Oregon Health & Science University.

Damien Fair (D)

Department of Psychiatry, Oregon Health & Science University.

Erica D Musser (ED)

Department of Psychology, Florida International University.

Joel T Nigg (JT)

Department of Psychiatry, Oregon Health & Science University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH